These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16571312)

  • 21. [Treatment of hepatitis C--recommendations by the specialty association are still valid].
    Franzén L
    Lakartidningen; 2000 Jan; 97(1-2):21-2. PubMed ID: 10668320
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C].
    Makashova VV; Florianu AI
    Ter Arkh; 2008; 80(11):7-10. PubMed ID: 19143182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis C in 2007...progress and challenges].
    Marcellin P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S3-6. PubMed ID: 17965628
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Aycock R
    Hepatology; 2000 Oct; 32(4 Pt 1):873; author reply 874-5. PubMed ID: 11041687
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical aspects of chronic hepatitis C infection.
    Leblebicioglu H
    JAMA; 2003 Sep; 290(11):1453; author reply 1453-4. PubMed ID: 13129977
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiology of hepatitis C and vaccine perspectives].
    Nau JY
    Rev Med Suisse; 2016 Jan; 12(503):234-5. PubMed ID: 26939196
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial commentary: Hepatitis C virus and the infectious disease physician: a perfect match.
    McGovern BH
    Clin Infect Dis; 2012 Aug; 55(3):414-7. PubMed ID: 22491341
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right.
    Tsochatzis EA; Crossan C; Longworth L
    J Hepatol; 2014 Aug; 61(2):453-4. PubMed ID: 24780301
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to: "Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right".
    Younossi ZM; Henry L; Singer M
    J Hepatol; 2014 Aug; 61(2):454-5. PubMed ID: 24824281
    [No Abstract]   [Full Text] [Related]  

  • 32. [The current status and prospect of treatment of hepatitis C. A discussion].
    Chayama K; Takehara T; Imamura M; Suzuki F; Mizuno Y
    Nihon Shokakibyo Gakkai Zasshi; 2009 Apr; 106(4):508-19. PubMed ID: 19346719
    [No Abstract]   [Full Text] [Related]  

  • 33. [Progress in the treatment of C-type hepatitis and future prospect. Discussion].
    Minami H; Hiramatsu N; Yatsuhashi H; Tanaka Y; Akutada N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1200-21. PubMed ID: 23029703
    [No Abstract]   [Full Text] [Related]  

  • 34. Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.
    Omland LH; Christensen PB; Krarup H; Jepsen P; Weis N; Sørensen HT; Obel N;
    PLoS One; 2011; 6(7):e22476. PubMed ID: 21789259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of chronic hepatitis C. The Danish Society of Infection Medicine].
    Weis NM; Christensen PB; Laursen AL
    Ugeskr Laeger; 2006 Mar; 168(12):1221. PubMed ID: 16571312
    [No Abstract]   [Full Text] [Related]  

  • 36. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of microarray analysis for predicting treatment responsiveness in patients with chronic hepatitis C viral infection.
    Kim IJ; Kang HC; Park JG
    Gastroenterology; 2005 Nov; 129(5):1803; author reply 1803-4. PubMed ID: 16285984
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging host cell targets for hepatitis C therapy.
    He Y; Duan W; Tan SL
    Drug Discov Today; 2007 Mar; 12(5-6):209-17. PubMed ID: 17331885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.